mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.
Understanding the 3D Shape of the Genome Reveals Future Cancer Drug Targets
Computer artwork representing brain cancer, with a cancer cell between two halves of a human brain. Researchers at Sanford Burnham Prebys have published new findings